Abnormal cytokinesis in cells deficient in the breast cancer susceptibility protein BRCA2
about
A mitotic function for the high-mobility group protein HMG20b regulated by its interaction with the BRC repeats of the BRCA2 tumor suppressorBRCA2 suppresses cell proliferation via stabilizing MAGE-D1Streamline proteomic approach for characterizing protein-protein interaction network in a RAD52 protein complexStructural basis for recruitment of BRCA2 by PALB2How the fanconi anemia pathway guards the genomeWhen 2+2=5: the origins and fates of aneuploid and tetraploid cellsDoes tumorigenesis select for or against mutations of the DNA repair-associated genes BRCA2 and MRE11?: considerations from somatic mutations in microsatellite unstable (MSI) gastrointestinal cancers.Targeting the Mitotic Catastrophe Signaling Pathway in CancerNon-muscle myosin II in disease: mechanisms and therapeutic opportunitiesThe role of the endosomal sorting complexes required for transport (ESCRT) in tumorigenesisThe Fanconi Anemia C Protein Binds to and Regulates Stathmin-1 PhosphorylationHomologous recombination and human health: the roles of BRCA1, BRCA2, and associated proteinsMolding BRCA2 function through its interacting partnersDSS1 is required for the stability of BRCA2Is there more to BARD1 than BRCA1?The Polycomb group protein EZH2 impairs DNA repair in breast epithelial cellsMinding the gap: the underground functions of BRCA1 and BRCA2 at stalled replication forksDNA damage response genes and the development of cancer metastasisE2F8 is essential for polyploidization in mammalian cellsBRCA2 is required for neurogenesis and suppression of medulloblastomaHomologs of breast cancer genes in plantsExpanded roles of the Fanconi anemia pathway in preserving genomic stabilityCytokinesis failure generating tetraploids promotes tumorigenesis in p53-null cellsExtensive crosstalk between O-GlcNAcylation and phosphorylation regulates cytokinesisEnlazin, a natural fusion of two classes of canonical cytoskeletal proteins, contributes to cytokinesis dynamicsThe DNA-damage effector checkpoint kinase 1 is essential for chromosome segregation and cytokinesis.Centriole movements in mammalian epithelial cells during cytokinesisCytokinesis failure occurs in Fanconi anemia pathway-deficient murine and human bone marrow hematopoietic cellsThe relative efficiency of homology-directed repair has distinct effects on proper anaphase chromosome separation.BRCA2 localization to the midbody by filamin A regulates cep55 signaling and completion of cytokinesis.Transgenerational cell fate profiling: a method for the graphical presentation of complex cell cycle alterationsA novel Markov Blanket-based repeated-fishing strategy for capturing phenotype-related biomarkers in big omics dataBrh2-Dss1 interplay enables properly controlled recombination in Ustilago maydis.The negative interplay between Aurora A/B and BRCA1/2 controls cancer cell growth and tumorigenesis via distinct regulation of cell cycle progression, cytokinesis, and tetraploidyGene network disruptions and neurogenesis defects in the adult Ts1Cje mouse model of Down syndrome.Mechanism of Aurora-B degradation and its dependency on intact KEN and A-boxes: identification of an aneuploidy-promoting propertyThe SET domain protein, Set3p, promotes the reliable execution of cytokinesis in Schizosaccharomyces pombe.Tumor characteristics as an analytic tool for classifying genetic variants of uncertain clinical significance.brca2 in zebrafish ovarian development, spermatogenesis, and tumorigenesisThe role of vertebrate nonmuscle Myosin II in development and human disease.
P2860
Q24297103-8FB28C63-20E6-4088-B5FE-139B6358CEAAQ24304364-37456229-8AE2-4A7E-A869-160E328E58B3Q24311465-1B0513AA-A0DD-4F20-B68F-35B14697676DQ24315745-66C09945-6741-4144-B9A5-A7BC7EB2ACB6Q24634556-CC6B1374-05F1-41E9-8609-A2647D18A278Q24658364-92F0D133-1D41-4B53-9CE2-A2DD4352F768Q25257372-93857F5D-6751-4FE3-9642-BEF74AE1F137Q26778544-184D626E-00D8-481A-A6D3-D1151CC17BA9Q26778962-A518B7E1-192E-48A6-A889-9C4A61DC9CF3Q26864942-E213D88D-0246-49EC-835B-3C7E8AE2A96EQ27312678-A63BB011-8182-445A-A3C6-9E65CB15583FQ28085364-087E1EFB-36E2-460E-84F8-3BB3021344FDQ28085603-B98D6037-2A55-4CC1-B6D9-A5598D4D38FEQ28115992-1D7CCA8A-789B-4B58-A4FB-DAF3C341CD71Q28236135-E94A0A03-5B67-40CA-967B-874494E97E5CQ28285316-C24020F7-54C5-461F-A2F6-83D9BDC2DCE2Q28294399-C9297E94-EF55-4F64-93DF-D54EEAC9BAF7Q28388312-FC006C60-B1C3-480C-BA25-E87B053E139AQ28510234-DF22F52B-C552-477D-9998-AFD2AD87D639Q28590758-974A6E20-FE1D-4C56-BEF8-6D95B5706534Q28729894-09301A98-4574-45B1-AD2A-8087273D5538Q28749668-821F252A-886A-4741-8183-74D8B15EF195Q29617924-ABE7906A-E8B8-4139-9EBC-D11EEDA6A3B2Q30436151-1BE91DED-8EE2-470D-BF95-683FC99511A0Q30478413-1F954C35-333C-48CD-9CF0-1C34D7AFCB9AQ30486781-12963EA6-206F-4404-8155-704139B3442AQ30495166-AA3A1B69-A528-4E3B-8D4E-B61C093D4517Q30497160-334F96A4-3ADB-4036-9A0F-24E8F4337356Q30503322-8D9981AB-2FB8-40D0-AB29-DA0731F1B3DEQ30524187-2F60CD22-9B2F-4861-9C3F-29406BF5586AQ30535409-7E84359F-FA51-431B-817D-636B27A52F98Q31055003-11ACA241-7546-41BC-AAE4-74FCEE866B75Q31153737-0F22BA62-A050-4BE0-9804-E1B4CE5B1A47Q33637754-BF278542-855D-417B-ADFD-7BF06CCD2403Q33641252-175D3FD1-6D70-4198-B069-1CB9FEB5E234Q33836931-796506C6-FBC4-4CCB-906B-044B540BE0B1Q34162742-97071398-65AD-4012-8CF3-A1D7B42C7FC0Q34252077-EAA2FA7D-3711-42B0-89A0-DB274D016C3CQ34320658-E3E11E17-CFB9-430D-BA5F-3EFDA556E78FQ34362453-CD1D3293-510B-48B3-9607-6410020E2791
P2860
Abnormal cytokinesis in cells deficient in the breast cancer susceptibility protein BRCA2
description
2004 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
article publié dans la revue scientifique Science
@fr
artículu científicu espublizáu en 2004
@ast
im Oktober 2004 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2004/10/29)
@sk
vědecký článek publikovaný v roce 2004
@cs
wetenschappelijk artikel (gepubliceerd op 2004/10/29)
@nl
наукова стаття, опублікована в жовтні 2004
@uk
name
Abnormal cytokinesis in cells deficient in the breast cancer susceptibility protein BRCA2
@ast
Abnormal cytokinesis in cells deficient in the breast cancer susceptibility protein BRCA2
@en
Abnormal cytokinesis in cells deficient in the breast cancer susceptibility protein BRCA2
@nl
type
label
Abnormal cytokinesis in cells deficient in the breast cancer susceptibility protein BRCA2
@ast
Abnormal cytokinesis in cells deficient in the breast cancer susceptibility protein BRCA2
@en
Abnormal cytokinesis in cells deficient in the breast cancer susceptibility protein BRCA2
@nl
prefLabel
Abnormal cytokinesis in cells deficient in the breast cancer susceptibility protein BRCA2
@ast
Abnormal cytokinesis in cells deficient in the breast cancer susceptibility protein BRCA2
@en
Abnormal cytokinesis in cells deficient in the breast cancer susceptibility protein BRCA2
@nl
P2093
P356
P1433
P1476
Abnormal cytokinesis in cells deficient in the breast cancer susceptibility protein BRCA2
@en
P2093
Ashok R Venkitaraman
Miyoung Lee
Yunmei Wang
P304
P356
10.1126/SCIENCE.1102574
P407
P577
2004-09-16T00:00:00Z